Back to Search
SANJAI SHARMA, MD
MD
Hematology & Oncology Physician
NPI: 1659458867IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A75974(CA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1985
Research & Publications (20)
Adenovirus E3 proteins help tumors to evade innate and adaptive immune responses.
PMID 19458480·Cancer Biol Ther·2009
8-other
Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma.
PMID 19393301·Neuroscience·2009
7-preclinical
Isolation of a sequence-specific RNA binding protein, polypyrimidine tract binding protein, using RNA affinity chromatography.
PMID 18982280·Methods Mol Biol·2008
8-other
Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors.
PMID 18515658·Blood·2008
8-other
Polypyrimidine tract binding protein controls the transition from exon definition to an intron defined spliceosome.
PMID 18193060·Nat Struct Mol Biol·2008
8-other
Maps, codes, and sequence elements: can we predict the protein output from an alternatively spliced locus?
PMID 17114042·Neuron·2006
6-review
Polypyrimidine tract binding protein blocks the 5' splice site-dependent assembly of U2AF and the prespliceosomal E complex.
PMID 16109373·Mol Cell·2005
8-other
Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responses.
PMID 16002678·J Immunol·2005
7-preclinical
Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
PMID 15958566·Cancer Res·2005
7-preclinical
Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
PMID 14577913·Hum Gene Ther·2003
7-preclinical
Natural killer cell cytolytic activity is necessary for in vivo antitumor activity of the dipeptide L-glutamyl-L-tryptophan.
PMID 12845648·Int J Cancer·2003
7-preclinical
Percutaneous intervention on the LIMA: tackling the tortuosity.
PMID 12777679·J Invasive Cardiol·2003
5-case
SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10.
PMID 12740040·Mol Cancer·2003
7-preclinical
Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.
PMID 12631593·Clin Cancer Res·2003
7-preclinical
Cyclooxygenase 2-dependent regulation of antitumor immunity in lung cancer.
PMID 12407775·Methods Mol Med·2003
7-preclinical
Intratumoral therapy with cytokine gene-modified dendritic cells in murine lung cancer models.
PMID 12407774·Methods Mol Med·2003
7-preclinical
Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
PMID 11522634·Cancer Res·2001
7-preclinical
Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo.
PMID 10779757·J Immunol·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11301 WILSHIRE BLVD, BLDG 304, RM E1-115
LOS ANGELES, CA 90073 - Phone
- (310) 368-3247
Quick Facts
- NPI
- 1659458867
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile